<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
Songtao Qi(Nanfang Hospital), Si Gui(Guangzhou First People's Hospital), Lei Yu(Taiyuan Central Hospital), Wu Lanxiao, Zhang Xue-lin(Nanfang Hospital)
Cited by 296
Related Papers
Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
|Molecular Cancer|2014|228